L

Lyrebird Health pricing

Starting price

Free and Bp Free plans at A$0

Pro A$160 a month billed annually; Enterprise custom

Published by Lyrebird Health

Plans and prices

Lyrebird Health prices in Australian dollars: Pro costs A$160 per clinician a month billed annually, two free plans cost A$0, and Enterprise is custom, with discounts for part time clinicians, registrars and practices.

Pro, A$160 per clinician a month billed annually

Free plan (50 transcribe and 10 document actions a month), Bp Free via Bp Premier, and a 14 day free trial

How billing works

Per clinician per month.

Enterprise runs on custom, flexible billing with tiered discounts, and SSO is an add-on.

What adds to the bill

Free plans cap monthly actions and exclude EMR integrations and care plans.

A flat per clinician rate means cost tracks headcount rather than consultation volume, with no per encounter or per note metering.

What Lyrebird Health does not state

Lyrebird Health does not state a month to month Pro price or the full usage limits for each tier.

Lyrebird Health against its alternatives

Starting prices for Lyrebird Health and the products closest to it, each in its own currency and billing unit.

  • Lyrebird HealthFree and Bp Free plans at A$0; Pro A$160 a month billed annually; Enterprise custom
  • SukiQuote only
  • Ambience HealthcareQuote only
  • NablaNo published price
  • Glass HealthFree Lite; Starter $20 a month; Pro $90; Max $200; API from $250 a month
  • Microsoft Dragon CopilotQuote only
  • AbridgeQuote only
  • CortiPay as you go: speech to text $0.0065 a minute, language APIs $4 and $16 per million tokens
  • DeepScribeQuote only
  • HeidiFree; Clinician Standard $150 per user a month, or $110 billed annually; Max $409 or $299
  • ScribeberryPro at $99 a month, or $999 a year, with unlimited use. Enterprise from $79 per user a month for 5 or more providers. Trial Mode is free, with 3 days unlimited, then 20 uses a month.

All Lyrebird Health alternatives →

Contact us

Found a vendor we missed? Have feedback on the index? We'd love to hear from you.